Barely Significant
← all phrases

near-significant

1,039 sentences · 1,039 papers · 5,323 search hits before verification · confirmed specimen

Listed by Otte et al. (2022)

In the literature

near-significantp = 0.0591.2× alphagold
placebo and showed a near-significant reduction in the primary composite of total HF hospitalisations and CV death (RR 0.79, 95% CI 0.62–1.01, p = 0.059), driven by fewer total HF hospitalisations (RR 0.74, 95% CI 0.58–0.94, p = 0.013), with no difference in CV death (HR 0.96, 95% CI 0.70–1.32, p = 0.81) [ 56 ].
Heart failure evidence update 2026.
Heart Fail Rev · 2026 · PMC12979370
near-significantp = 0.061.2× alphagold
Subgroup analysis showed that CE significantly reduced BMI (MD = −1.25, 95% CI: [−1.96, −0.55], p < 0.001), AR showed a near-significant reduction (MD = −2.60, 95% CI: [−5.36, 0.16], p = 0.06), and RT did not reduce BMI (MD = −1.40, 95% CI: [−3.26, 0.46], p = 0.14).
near-significantp = 0.0601.2× alphagold
2 D) also increased significantly with older Age: F (6,14) = 9.54, p < 0.001, η p 2 = 0.80, and was higher in males ( M = 1.18 ng/mL, SD = 0.25) compared to females ( M = 0.96 ng/mL, SD = 0.17): F (1,14) = 26.04, p < 0.001, η p 2 = 0.65, which only occurred after the age of 45 as evidenced by a near-significant Sex × Age interaction: F (6,14) = 2.67, p = 0.060, η p 2 = 0.54.
near-significantP = 0.061.2× alphagold
On the other hand, Insulin Delivery Systems: Perspectives, Ideas, Reflections, and Expectations [INSPIRE score] showed a near-significant increase among ultra-rapid insulin users [MD 3.98, 95% CI [-0.24 to 8.2], P = 0.06, I 2 = 20] ( Supplementary Figure 35b ). 3.6.
near-significantP = .061.2× alphagold
We did observe a near-significant decrease in the number of game starts for all athletes at 2 years after injury compared with before (median of 8 starts after injury versus 13.5 before; P = .06), despite similar numbers of games played (15 games after injury versus 15 before; P = .38) and snaps played (613.6 snaps after injury versus 637.3 snaps before; P = .91).
near-significantP =.061.2× alphagold
The analyses of the other outcomes in the placebo group revealed that there was a significant difference in the rates of overall PTD at <34 weeks of gestation ( P =.01), a near-significant difference in sPTD at <37 weeks of gestation ( P =.06), and a nonsignificant difference for overall PTD at <37 weeks of gestation ( P =.19) ( Supplemental Table 1 ).